Early detection of kidney disease is now possible with a simple blood test, as a protein-based risk score can predict kidney ...

The patient in the current case report showed manifestations of both AAV and IgG4-RD; his improvement linked to steroid/cyclophosphamide treatment underscores the need for integrated diagnosis and ...

By analyzing protein markers, a blood test identifies those most likely to develop kidney failure years ahead, enabling ...

The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...

It might not be too late to invest in this company.

Perha Pharmaceuticals has discovered new pyrazolo[1,5-a]pyrimidine derivatives acting as adenosine A3 receptor antagonists potentially useful for the treatment of ulcerative colitis, atopic dermatitis ...

VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.